Abstract:Objective: To investigate the effect of continuous veno-venous hemofiltration (CVVH) in the treatment of acute severe hyponatremia. Methods: Six patients with acute severe hyponatremia were studied, including 5 males and 1 female, aged 48.5 (25 - 61) years. Clinical manifestations of hyponatremia included confusion (6/6), drowsiness (3/6), and delirium (3/6). The course of hyponatremia before the initiation of CVVH was 45 - 48 hours. AN69, AV600, FH66 and HF1200 hemofilters were applied and changed every 24 hours. The ultrafiltration rate was 2 000 ml/h, with a blood flow rate of 200 - 250 ml/min, and the substitute fluid was infused by a pre-dilution route. Low molecular weight heparin was used for anticoagulation. Results: The average treatment duration of CVVH was 59.7 (45.6 - 86) hours. All the patients survived and tolerated CVVH well. During CVVH, the serum sodium increased significantly from (101.2 +/- 4.2) mmol/L before CVVH, to (115.0 +/- 2.7) mmol/L at the 6th hour of CVVH, (129.2 +/- 4.1) mmol/L at the 24th hour, and (140.3 +/- 1.6) mmol/L at the 48th hour of CVVH; with the correction rate of serum sodium controlled at (2.5 +/- 0.4) mmol.L(-1).h(-1) over the first 24 hours, (1.2 +/- 0.1) mmol.L(-1).h(-1) for the first 48th hour, and the correction rate of (0.82 +/- 0.10) mmol.L(-1).h(-1). The sodium concentrations in the replacement solution were (16.0 +/- 6.0) mmol/L higher than the serum sodium concentration at 0 hour, (11.6 +/- 4.3) mmol/L higher at 4th hour, (5.5 +/- 5.1) mmol/L higher at 24th hour, and (0.75 +/- 0.96) mmol/L higher at 48th hour of CVVH. After CVVH, the serum osmolarity increased significantly, from (216.7 +/- 7.4) mOsm/kgH(2)O pre-CVVH, to (245.0 +/- 5.5) mOsm/kgH(2)O at 6th hour, with a correction rate of (5.16 +/- 0.81) mOsm.kgH(2)O(-1).h(-1); (272.7 +/- 7.1) mOsm/kgH(2)O at 24th hour, with a correction rate of (2.33 +/- 0.28) mOsm.kgH(2)O(-1).h(-1); and (295.0 +/- 4.2) mOsm/kgH(2)O at 48th hour, with a correction rate of (1.63 +/- 0.20) mOsm.kgH(2)O(-1).h(-1). The Glasgow scores and APACHEII scores improved significantly as compared to pretreatment. Conclusion: CVVH is effective in the treatment of acute severe hyponatremia, and could be considered as a treatment option because of its slow and continuous nature. A low-sodium replacement solution should be prepared to minimize its sodium concentration difference from the serum concentration. We recommend that the serum sodium concentration be corrected at an average rate of (2.50 +/- 0.14) mmol.L(-1).h(-1) at 6 h, (1.2 +/- 0.1) mmol.L(-1).h(-1) at 24 h and (0.82 +/- 0.10) mmol.L(-1).h(-1) at 48 h.

Nursing Care of Continuous Veno-Venous Hemofiltration for Patients with Hepatorenal Syndrome

Application of Continuous Veno-Venous Hemodiafiltration to Severely Acute Renal Failure after Cardiac Surgery

Clinlic Study of Continuous Venovenous Hemofiltration in Treatment of Hepatorenal Syndrome

Clinical Analysis of Continuous Venovenous Hemofiltration in Patients with Severe Congestive Heart Failure

Hypophosphatemia During Continuous Veno-Venous Hemofiltration is Associated with Mortality in Critically Ill Patients with Acute Kidney Injury

The effect of continuous renal replacement therapy in patients with acute kidney injury on the serum levels of urea,creatinine and cystatin C

Comparison of the effects between continuous veno-venous hemofiltration and hemodialysis on patients with uremic encephalopathy

Continuous Veno-Venous Hemofiltration in Treatment of Acute Severe Hyponatremia:A Report of 6 Cases

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

[Continuous veno-venous hemofiltration in treatment of acute severe hyponatremia: a report of 6 cases]

Continuous Venovenous Hemofi Ltration with Citrate Based,calcium-,Mag Nesium-Free Replacement Solution in Acut E Renal Failure Patients at High Risk of Bleeding

The Effect of Substitution Fluid Rate on the Prognosis of Critical Acute Kidney Injury Patients Treated with Continuous Veno-Venous Hemorfltration Therapy

Variables Associated with Circuit Life Span in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: a Prospective Observational Study.

Management of hepatorenal syndrome in liver cirrhosis: a recent update

Effects of Continuous Veno-Venous Hemofiltration in Gerontal Patients with Multiple Organ Failure

[Continuous veno-venous haemofiltration in adult intensive therapy]

Research progress in diagnosis and treatment of hepatorenal syndrome

Effect of the Application of Continuous Cenous Venous Hemofiltration on Pulmonary Vascular Permeability in the Early Stage of Septic Shock

Hyponatremia in Critically Ill Patients Due to Continuous Venovenous Hemofiltration With Diluted Sodium Citrate

The Early Application of Continuous Renal Replacement Therapy in Acute Renal Failure after Cardiac Surgery

Changes of the Plasma Amino Acid Level in Patients with Abdominal Inflammation and Acute Renal Failure During Continuous Veno-Venous Hemofiltration